Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients

KÜRTÜNCÜ M., TÜZÜN E., Balcı B., Birday E., ÇOBAN A., Türkoğlu R., ...Daha Fazla

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 Ekim 2013

  • Yayın Türü: Bildiri
  • İstanbul Üniversitesi Adresli: Evet